Source:http://linkedlifedata.com/resource/pubmed/id/10051270
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-4-1
|
pubmed:abstractText |
Previous studies suggest that lung function tests using monodisperse aerosols can help to identify early stages of lung diseases. We investigated intrapulmonary particle loss and aerosol bolus dispersion-a marker of convective gas transport-in 32 women with asymptomatic nonspecific bronchial hyperresponsiveness (BHR) compared with 60 women without BHR. Deposition of inhaled particles (0.9 micrometer mass median aerodynamic diameter [MMAD]) was calculated from particle losses of inhaled aerosol boluses consisting of di-2-ethylhexyl sebacate droplets. Convective gas mixing was assessed by the aerosol bolus dispersion method. Women with BHR, nonsmokers as well as smokers, showed significantly increased deposition of aerosol particles (nonsmokers: 45.6 +/- 8.8%; smokers: 49.2 +/- 5.4%; mean +/- SD) compared with the control group of female nonsmokers without BHR (38.2 +/- 9.1%; mean +/- SD) (p < 0.01). Aerosol bolus dispersion values showed a trend for higher values in subjects with BHR (nonsmokers: 572 +/- 122 cm3; smokers: 587 +/- 85 cm3) compared with the control group (542 +/- 88 cm3) (p = 0.2). Also, the maximal expiratory flow at 25% vital capacity (MEF25) showed a trend for decreased values in nonsmokers with BHR compared with nonsmokers without BHR (64 +/- 16% of predicted versus 78 +/- 24% of predicted; p = 0.03). These results suggest that deposition of inhaled particles (0.9 micrometer MMAD) administered by the aerosol bolus technique is a sensitive index of peripheral lung injury that is usually not assessable by conventional methods.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
902-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10051270-Adult,
pubmed-meshheading:10051270-Aerosols,
pubmed-meshheading:10051270-Bronchial Hyperreactivity,
pubmed-meshheading:10051270-Bronchial Provocation Tests,
pubmed-meshheading:10051270-Decanoic Acids,
pubmed-meshheading:10051270-Female,
pubmed-meshheading:10051270-Humans,
pubmed-meshheading:10051270-Lung,
pubmed-meshheading:10051270-Methacholine Chloride,
pubmed-meshheading:10051270-Particle Size,
pubmed-meshheading:10051270-Plethysmography, Whole Body,
pubmed-meshheading:10051270-Respiratory Mechanics,
pubmed-meshheading:10051270-Smoking,
pubmed-meshheading:10051270-Spirometry
|
pubmed:year |
1999
|
pubmed:articleTitle |
Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness.
|
pubmed:affiliation |
Clinical Research Group "Aerosols in Medicine" of the GSF-Institute for Inhalation Biology and the Center for Respiratory Medicine, Munich-Gauting, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|